Acadia Pharmaceuticals Inc (ACAD)
R&D Expenses
$331.01M
TTM · Period ending: · USD
ACAD R&D Expenses
Latest reported$331.01Mperiod ending
Latest reported$331.01Mperiod ending
ACAD R&D Expenses ($9.73M → $331.01M)
Annual R&D Expenses
High-resolution chart · PNG
ACAD r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 328,802,000 | |
| 303,249,000 | |
| 351,619,000 | |
| 361,575,000 | |
| 239,415,000 | |
| 319,130,000 | |
| 240,385,000 | |
| 187,163,000 | |
| 149,189,000 | |
| 99,284,000 | |
| 73,869,000 | |
| 60,602,000 | |
| 26,722,000 | |
| 18,794,000 | |
| 17,309,000 | |
| 20,579,000 | |
| 41,585,000 | |
| 56,750,000 | |
| 57,942,000 | |
| 49,398,000 | |
| 30,848,000 | |
| 23,454,000 | |
| 16,935,000 | |
| 14,920,700 | |
| 13,090,000 | |
| 9,728,000 |